PURE Bioscience, a developer of technology-based bioscience products, has appointed John J. Carbone to its board. Carbone replaced Murray Gross, who has resigned on February 13, 2009. Carbone is a board certified orthopedic surgeon and a fellow of the American Academy of Orthopedic Surgeons. Since 2004, he has served as the director, orthopedic spine services at Harbor Hospital in Baltimore.

Michael L. Krall, president/chief executive officer and chairman of PURE Bioscience, commented, We believe that SDC has tremendous potential in numerous healthcare applications, and we are extremely pleased and honored to have someone with Dr. Carbone’s experience and leadership on our Board. Dr. Carbone’s guidance will be a great benefit to PURE in our efforts to fully develop a market for SDC in healthcare.

Carbone stated, I have always been fascinated with new technologies in my field, and I think that the SDC molecule presents intriguing and promising opportunities in medicine. I’m looking forward to supporting the research for and commercialization of SDC in medicine.

Carbone is specialist in the design and use of orthopedic implants and surgical instruments as well as the biomechanics and clinical outcomes of spinal surgery. Currently, he has several patents for orthopedic prosthetic devices and implants and is a consulting surgeon to the National Aquarium in Baltimore, managing director. Carbone is expert in the treatment of all types of spinal pathology from degenerative cervical and lumbar disease to reconstructive deformity, failed spine surgery syndrome, and minimally invasive spinal surgery.

Carbone has earned his bachelor’s degree in engineering from The United States Merchant Marine Academy in 1983. He then served as a marine engineer for Military Sealift Command until 1988. He has been awarded an honorable discharge as a lieutenant in the United States Naval Reserve in 1993. He has earned his medical degree from the University of Maryland School of Medicine in 1992. He completed his orthopedic residency training at The Johns Hopkins Hospital and his reconstructive spinal surgery fellowship under John Kostuik. Concurrent with his early medical career, Carbone also served in senior executive positions at two orthopedic research and design companies.

Carbone’s combination of medical and engineering talents has led to a distinguished career in orthopedics research and design. His primary research specialist on the biomechanical design and use of orthopedic implants in spinal fusion.

Carbone serves on the PURE Bioscience board as an independent director and a member of the audit committee. Carbone is not, and has not been for the past three years, employed by the company or by any parent or subsidiary of the company and has not accepted any payments from the company or any parent or subsidiary of the company during the current or any of the past three fiscal years.